EUVIMEDEUVIMED entdecken
Open Access

Pulmonary Embolism‐Attributable Mortality in Patients With Atherosclerotic Cardiovascular Disease in the United States from 2010 to 2023

Marco Zuin iD, Claudio Bilato, Gianluca Rigatelli, Samuel Goldhaber iD, Gregory Piazza iD

Journal of the American Heart Association · 20.10.2026 · 15 (20)

DOI: 10.1161/jaha.126.049510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 20.10.2026. Verfasst von Marco Zuin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine University of Ferrara Ferrara Italy. Hauptthemen laut MEDLINE: Pulmonary Embolism, Atherosclerosis. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with atherosclerotic cardiovascular disease (ASCVD) are at increased risk of pulmonary embolism (PE) and related mortality, yet contemporary US trends remain incompletely defined. We examined PE‐attributable mortality from 2010 to 2023 among patients with ASCVD, stratified by age, sex, race, ethnicity, urbanization, and region.

Methods

We used the Centers for Disease Control and Prevention's Wide‐Ranging Online Data for Epidemiologic Research data (2010–2023) to assess PE‐attributable mortality among patients with ASCVD aged ≥15 years using age‐adjusted mortality rates. Concurrent trends in age‐adjusted ASCVD prevalence and risk factors were evaluated using NHANES (National Health and Nutrition Examination Survey). Age‐adjusted mortality rates were analyzed with Joinpoint regression to estimate average annual percentage change (95% CI), and trends in NHANES were assessed using linear models.

Results

From 2010 to 2023, 152 386 US patients with ASCVD aged ≥15 years (80 015 male, 72 371 female) died from PE. PE‐attributable AAMR rose from 3.62 to 4.96 per 100 000 (annual percentage change +3.1%; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismAtherosclerosisHumansMaleFemaleUnited StatesMiddle AgedAgedAdultRisk FactorsNutrition SurveysPrevalenceYoung AdultAdolescentRisk AssessmentTime Factors

Stichwörter der Autor:innen

atherosclerotic diseasemortalitypulmonary embolismtrend

Autor:innen und Institutionen

  • Department of Translational Medicine University of Ferrara Ferrara Italy.
  • Department of Cardio-Thoraco-Vascular Sciences and Public Health University of Padova Padua Italy.
  • PhD Program in Translation Specialistic Medicine "G.B. Morgagni", Curriculum Cardiovascular Sciences University of Padua Padua Italy.
  • Department of Cardiology, Madre Teresa Di Calcutta Hospital AULSS 6, Ospedali Riuniti Padova Sud Monselice Italy.
  • Department of Cardiology West Vicenza Hospitals Arzignano, Vicenza Italy.
  • Division of Cardiovascular Medicine Brigham and Women's Hospital Harvard Medical School Boston MA USA.

ORCID-Profile: Marco Zuin, Samuel Goldhaber, Gregory Piazza

Zitieren

APA

Zuin, M., Bilato, C., Rigatelli, G., Goldhaber, S., & Piazza, G. (2026). Pulmonary Embolism‐Attributable Mortality in Patients With Atherosclerotic Cardiovascular Disease in the United States from 2010 to 2023. Journal of the American Heart Association, 15(20). https://doi.org/10.1161/jaha.126.049510

Vancouver

Zuin M, Bilato C, Rigatelli G, Goldhaber S, Piazza G. Pulmonary Embolism‐Attributable Mortality in Patients With Atherosclerotic Cardiovascular Disease in the United States from 2010 to 2023. Journal of the American Heart Association. 2026;15(20). doi:10.1161/jaha.126.049510

BibTeX
@article{Zuin2026,
  author = {Zuin, Marco and Bilato, Claudio and Rigatelli, Gianluca and Goldhaber, Samuel and Piazza, Gregory},
  title = {Pulmonary Embolism‐Attributable Mortality in Patients With Atherosclerotic Cardiovascular Disease in the United States from 2010 to 2023},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {20},
  doi = {10.1161/jaha.126.049510}
}
Kostenlos starten →